A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea

Journal of Hypertension

Volumn 32, Issue 8, 2014, Pages 1650-1657

  Lloberes, Patricia ^a,b   Sampol, Gabriel ^a,b   Espinel, Eugenia ^c   Segarra, Alfons ^c   Ramon, Maria Antònia ^a,b   Romero, Odile ^b,d   Ferrer, Roser ^a   Martínez Garcia, Miguel Angel ^b,e   Tovar, José Luis ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Servei de Nefrologia   (Spain)

^d Unitat d'Ele ctromiografia   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

24 h blood pressure monitoring; airway pressure; aldosterone; continuous positive; hyperaldosteronism; hypoxemia; obstructive sleep apnea; resistant hypertension

Indexed keywords

ALDOSTERONE; RENIN;

ADULT; AIRWAY PRESSURE; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANT HYPERTENSION; SLEEP DISORDERED BREATHING; WHITE COAT HYPERTENSION; AGED; BLOOD; BLOOD PRESSURE; DRUG RESISTANCE; HYPERTENSION; MIDDLE AGED;

AGED; ALDOSTERONE; BLOOD PRESSURE; CONTINUOUS POSITIVE AIRWAY PRESSURE; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RENIN; SLEEP APNEA, OBSTRUCTIVE;

EID: 84904053217     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000238     Document Type: Article

References (43)

1. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, et al. High prevalence of cardiac and extracardiac organ damage in refractory hypertension. J Hypertens 2001; 19:2063-2070. (Pubitemid 33035812)
2. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug resistant hypertension. J Hypertens 2001; 19:2271-2277. (Pubitemid 33135251)
3. Martinez-Garcia MA, Gomez-Aldaravi R, Gil-Martinez T, Soler-Cataluña JJ, Bernacer-Alpera B, Roman-Sanchez P. Sleep-disordered breathing in patients with difficult-to-control hypertension. Arch Bronconeumol 2006; 42:14-20. (Pubitemid 43253807)
4. Goncalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I, et al. Obstructive sleep apnea and resistant hypertension. A case-control study. Chest 2007; 132:1858-1862.
5. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Dernaika TA, Kinasewitz GT, Tawk MM. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131:453-459.
6. Lloberes P, Lozano L, Sampol G, Romero O, Jurado MJ, Ŕos J, et al. Obstructive sleep apnoea and 24 h blood pressure in patients with resistant hypertension. J Sleep Res 2010; 19:597-602.
7. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40:892-896. (Pubitemid 35434912)
8. Florczak E, Prejbisz A, Szwench-Pietrasz E, Sliwin'ski P, Bieleń P, Klisiewicz A, et al. Clinical characteristics of patients with resistant hypertension: The RESIST-POL study. J Hum Hypertens 2013; 27:678-685.
9. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, et al. Obstructive sleep apnea: The most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011; 58:811-817.
10. Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: The renin-angiotensin system. J Appl Physiol 2002; 92:627-633. (Pubitemid 34671030)
11. Tamisier R, Gilmartin GS, Launois SH, Pépin JL, Nespoulet H, Thomas R, et al. A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep and blood pressure. J Appl Physiol 2009; 107:17-
12. Foster GE, Hanly PJ, Ahmed SB, Beaudin AE, Pialoux V, Poulin MJ. Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism. Hypertension 2010; 56:369-377.
13. Gonzaga CC, Gaddam KK, Ahmed MI, Pimenta E, Thomas SJ, Harding SM, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 2010; 6:363-368.
14. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004; 125:112-117. (Pubitemid 38114572)
15. Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Su MC, Bradley TD, et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009; 179:241-246.
16. Friedman O, Bradley TD, Chan CT, Parkes R, Logan AG. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension. Hypertension 2010; 56:1077-1082.
17. Pimenta E, Calhoun DA, Oparil S. Sleep apnea, aldosterone, and resistant hypertension. Prog Cardiovasc Dis 2009; 51:371-380.
18. Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: A preliminary report. J Hum Hypertens 2010; 24:532-537.
19. Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea and aldosterone: Theory and therapy. Hypertension 2004; 43: 518-524. (Pubitemid 38282420)
20. Lozano L, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: A randomized, controlled trial. J Hypertens 2010; 28:2161-2168.
21. Martínez-Garcá MA, Gómez-Aldarav́ R, Soler-Cataluña JJ, Martínez TG, Bernácer-Alpera B, Román-Sanchez P. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Resp J 2007; 29:1-7.
22. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, et al. Refractory hypertension and sleep apnea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21:241-247. (Pubitemid 36204537)
23. Pedrosa RP, Drager LF, G de Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G. Effects of obstructive sleep apnea treatment on blood pressure in patients with resistant hypertension: A randomized trial. Chest 2013; 144:1487-1494.
24. Martínez-Garcá MA, Capote F, Campos-Rodŕguez F, Lloberes P, Dáz de Atauri MJ, Somoza M, et al., Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: The HIPARCO randomized clinical trial. JAMA 2013; 310:2407-2415.
25. Chobanian] AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252. (Pubitemid 37553153)
26. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
27. Masa JF, Jiménez A, Durán J, Capote F, Monasterio C, Mayos M, et al. Alternative methods of titrating continuous positive airway pressure: A large multicenter study. Am J Respir Crit Care Med 2004; 170:1218-1224. (Pubitemid 39577381)
28. Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, Johnson AL. Improvement of medication compliance in uncontrolled hypertension. Lancet 1976; 1:1265-1268.
29. Torpy DJ, Stratakis CA, Chrousos GP. Hyper-and hypoaldosteronism. Vitam Horm 1999; 57:177-216.
30. Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA. Characterization of resistant hypertension: Association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Arch Intern Med 2008; 168:1159-1164. (Pubitemid 351831398)
31. Lijnen P, Staessen J, Fagard R, Amery A. Increase in plasma aldosterone during prolonged captopril treatment. Am J Cardiol 1982; 49:1561-1563. (Pubitemid 12060503)
32. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al., 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
33. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure. Hypertension 2006; 47:846-853. (Pubitemid 44297554)
34. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population [Pressione Arteriose Monitorate E Loro Associazioni (PAMELA) Study]. Circulation 2001; 104:1385-1392. (Pubitemid 32880151)
35. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Grassi G, et al. Increased long-term risk of new-onset diabetesmellitus in white-coat and masked hypertension. J Hypertens 2009; 27:1672-1678.
36. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54:226-232.
37. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904.
38. Møller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16:274-280. (Pubitemid 36384754)
39. Meston N, Davies RJ, Mullins R, Jenkinson C, Wass JA, Stradling JR. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 2003; 254:447-454. (Pubitemid 37346628)
40. Saarelainen S, Hasan J, Siitonen S, Seppälä E. Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea. J Sleep Res 1996; 5:181-185. (Pubitemid 26380247)
41. Svatikova A, Olson LJ, Wolk R, Phillips BG, Adachi T, Schwartz GL, et al. Obstructive sleep apnea and aldosterone. Sleep 2009; 32:1589-1592.
42. Rifkin DE, Khaki AR, Jenny NS, McClelland RL, Budoff M, Watson K, et al. Association of renin and aldosterone with ethnicity and blood pressure: The Multi-Ethnic Study of Atherosclerosis. Am J Hypertens 2014; [Epub ahead of print].
43. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001; 37:699-705.